Abstract
In some antiretroviral drug distribution programmes, free drugs are provided only, or preferentially, to patients who are treatment-naive. Colebunders and colleagues argue that such a restricted policy is highly problematic.
MeSH terms
-
Acquired Immunodeficiency Syndrome / drug therapy*
-
Acquired Immunodeficiency Syndrome / economics*
-
Anti-Retroviral Agents / economics*
-
Anti-Retroviral Agents / therapeutic use*
-
Eligibility Determination
-
Health Services Accessibility*
-
Humans
-
Patient Selection
-
Uganda